Concord Medical Group PRIME

New York, New York 10016

0 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Ulcerative Colitis

Studies at this site

• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early